Reader Question:
Let Payer Guide Screening Pap Code Choice
Published on Sat Oct 09, 2010
Question:
Our lab performs a liquid-based screening Pap, and finding abnormality, refers the slide to the pathologist who diagnoses LGSIL. How should we code these procedures? Tennessee Subscriber
Answer:
The answer will be different depending on several factors such as the payer and lab method used.
Select the appropriate code for the liquid-based screening Pap smear technical charge based on your payer and lab method. For non-Medicare, choose from four CPT thin layer preparation codes depending on the screening/rescreening method:
- 88142 -- Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; manual screening under physician supervision
- 88143 -- ... with manual screening and rescreening under physician supervision
- 88174 -- ... screening by automated system, under physician supervision
- 88175 -- ... with screening by automated system and manual rescreening or review, under physician supervision
- For Medicare, select the appropriate HCPCS Level II "G" code based on the same criterion:
- G0123 -- Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision
- G0143 -- ... with manual screening and rescreening by cytotechnologist under physician supervision
- G0144 -- ... with screening by automated system under physician supervision
- G0145 -- ... with screening by automated system and manual rescreening under physician supervision
Pathologist interpretation takes additional code:
For the interpretation of any abnormal Pap tests billed with a CPT code, you should report 88141 (
Cytopathology, cervical or vaginal [any reporting system], requiring interpretation by physician).
For screening Medicare Pap tests using liquid-based technology, you should report the professional interpretation of an abnormal Pap using G0124 (Screening cytopathology, cervical or vaginal [any reporting system], collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician).